DGX vs SGMT · P/E 22, rev $5.94B vs $403.2M cap
Quest Diagnostics Incorporated (DGX) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
SGMT does not have a complete income-statement cache yet.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the DGX and SGMT stock pages for the full models.
Not investment advice.